Form 4: Bioxytran Director Radka Milanova Acquires 70,423 Shares of Common Stock
SEC Form 4
Radka Milanova, a director of Bioxytran, Inc. (BIXT), reported the acquisition of 70,423 shares of common stock at a price of $0.142 per share on April 19, 2024.
Summary
- On April 19, 2024, Radka Milanova, a director of Bioxytran, Inc. (BIXT), acquired 70,423 shares of common stock.
- The purchase price was $0.142 per share.
- Following the transaction, Milanova directly owns 955,222 shares of Bioxytran.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of a director's stock purchase. The purchase itself could be seen as a slightly positive signal, but without further context, it's difficult to assess the overall impact.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. This allows the public to see if directors are buying or selling shares in their own companies.
Key Dates
| Date | Description |
|---|---|
| 01/19/2024 | Date of Earliest Transaction |
| 04/19/2024 | Transaction Date: Acquisition of 70,423 shares |
Keywords
Bioxytran, BIXT, Radka Milanova, Director, Stock Acquisition, Form 4, Beneficial Ownership, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.